Table 2.

Neutropenia and infections during the procedure (day 0–day 30) according to G-CSF administration.

Day 0–Day 30	Early G-CSF		Control		p
	n	%	n	%
Grade IV neutropenia (<0.5 G/L)
Prevalence d0–30, n (%)	24	73%	71	80%	0.46
Duration (d), median (range)	4 (0–6)	–	5 (2–8)	–	0.18
Duration of G-CSF administration during D0–D30 median (range)	5 (4–6)	–	2 (0–5)	–	0.28
Febrile neutropenia
Prevalence D0–D30, n (%)	19	57.6%	72	80.9%	0.018
Early infection (d0–30) n (%)	11	33.3%	26	29.2%	0.66
Bacterial, n (%)	10	30.3%	18	20.22%	0.33
Viral, n (%)	4	12.1%	14	15.7%	0.78
Fungal, n (%)	1	3%	2	2.25%	1